Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome

2002/10/11 by Shashikant Mahadik, S Mahadik · 5 citations
Medicine · #Apolipoprotein B #Cholesterol #Diabetes, Cardiovascular Risks, and Lipoproteins #Diet and metabolism studies #Economics #Internal medicine #Medicine #Outcome (game theory) #Plasma levels #Psychiatry #Schizophrenia (object-oriented programming) #Schizophrenia research and treatment

paper · doi:10.1016/s0920-9964(01)00378-4

openalex publication_date 2002/10/11 · crossref created 2002/10/11 · crossref issued 2002/11/01 · crossref published 2002/11/01 · crossref published-print 2002/11/01 · crossref deposited 2019/05/03 · openalex created_date 2025/10/10 · crossref indexed 2025/11/02 · openalex updated_date 2026/08/01

Citations

• Arachidonic acid binds to apolipoprotein D: implications for the protein's function
• The Brief Psychiatric Rating Scale
• Glutamate Receptor Dysfunction and Schizophrenia
• Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients
• Identification, characterization, and tissue distribution of apolipoprotein D in the rat.

Cited by

• Structural Insight into the Dual Ligand Specificity and Mode of High Density Lipoprotein Association of Apolipoprotein D
• Apolipoprotein D: An overview of its role in aging and age-related diseases
• Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain
• Apolipoprotein D
• Apolipoprotein D [wikipedia]